Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature.

Olugbenga Akindele SilasChad J AchenbachRobert Leo MurphyLifang HouSolomon Atiene SagayEdmund BanwatAdeyi A AdogaJonah MusaDustin Douglas French

Published in: Expert review of vaccines (2017)

Most studies on cost-effectiveness of HPV vaccine in LMICs show that lowering cost of HPV vaccination with or without Pap smear screening is cost-effective in areas with high incidence of cervical cancer.

Keyphrases

high grade
endothelial cells
risk factors
cervical cancer screening
pulmonary tuberculosis
induced pluripotent stem cells
mycobacterium tuberculosis
disease virus